logo

Sir, In the field of non-muscle-invasive bladder cancer (NMIBC), accumulating data on hexaminolevulinate (HAL) or 5-aminolevulinic acid (5-ALA)-guided blue-light cystoscopy (BLC) s[...]
Sir, I am writing this from a trainee viewpoint. I was delighted to read your article on rights regarding PSA testing in February [1]. I know it’s not February or Valentine’s Day n[...]
Sir, I am writing this from a trainee viewpoint. I was delighted to read the articles by Khan et al. [1] and Elsamra et al. [2]. Both articles highlight how much the role of the su[...]
Sir, Khan et al. [1] present a new review of the use of learning curves (LCs) in clinical practice. It is enlightening to see how many confounding factors are involved when constru[...]
Sir, We read with great interest the paper by Oh et al. [1] and the paper by Pater et al. [2]. Their study confirmed the previously reported inverse relationship between prostate-s[...]
Sir, We read the article by Carrasco et al. [1] with interest. The study is worth attention as it relates to short-term CoQ10 use to prevent renal damage caused by SWL. However, so[...]
From simulation to reality: the path forward for the trainee robotic surgeon Sir, As a trainee, I was delighted to see the articles from Hung et al. [1] and Murphy et al. [2] in th[...]
Sir, Krege et al. [1] report on the results of adding sorafenib to standard cisplatin and gemcitabine (CG) in first-line advanced urothelial cancer. Despite reporting on negative f[...]
Sir, In the Mangera et al. [1] study various natural and synthetic scaffold materials, potentially applicable for tissue engineering purposes, were carefully compared. Primarily th[...]
Sir, We read with great interest the paper by Bedke et al. [1], which showed that using C-reactive protein (CRP) as a biomarker, with 0.25mg/dL as a threshold, did not improve pred[...]